Clinical Trial Update: Correction of Neonatal Glutathione by N-acetylcysteine in Pregnant Women at Risk of Premature Birth (GSH MAP) [Phase 2, Phase 3]

View source ↗

Summary

A neonatal glutathione correction trial using N-acetylcysteine in pregnant women at risk of preterm birth has been terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Delivery
• Preterm Birth
• Preterm Delivery

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Nantes University Hospital | Conditions: Preterm Delivery | Phase 2, Phase 3 | Status: TERMINATED